Dr. Bill Mason heads the EU operation for Sage Group, as Executive Director of Sage Healthcare Ltd based in Cambridge and London.

Bill Mason gained his doctorate in life sciences from Trinity College, Cambridge, in the UK. Prior to his successful business career, he led an academic programme of medical research focused on the use of cell and molecular biology, medical imaging and high throughput screening. He has over 150 publications and has lectured widely around the world. He is the founder of several successful high technology companies. One of these, Life Science Resources, was sold to Perkin Elmer Life Sciences PLC, and was engaged in medical imaging, high throughput screening and drug discovery.

He has worked with a number of healthcare, life science and biotech companies to develop their strategic direction, realise funding, gain value for shareholders and implement business development, commercialisation and licensing activity. In this capacity, he has conducted over 50 transactions in the last five years.

Dr. Mason is a member of the 3i PLC Independent Directors Programme and also acts as a non-executive Chairman or Director for a portfolio of quoted and unquoted life science companies. He is Chairman of Cytomyx PLC in the UK which he took to an IPO in 2001. He is also on the Board of Amarin plc, a pharmaceutical company listed on the NASDAQ exchange in the USA. He is a founding Advisory Board Member of the Cambridge Gateway Fund, and works with them and other venture capital institutions in guiding early stage companies